Ramon García-Sanz

Ramon García-Sanz

UNVERIFIED PROFILE

Are you Ramon García-Sanz?   Register this Author

Register author
Ramon García-Sanz

Ramon García-Sanz

Publications by authors named "Ramon García-Sanz"

Are you Ramon García-Sanz?   Register this Author

100Publications

5746Reads

21Profile Views

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Leukemia 2019 Sep 9;33(9):2324-2330. Epub 2019 Apr 9.

ProfilExpert, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0452-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756025PMC
September 2019

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.

Hematol Oncol 2019 Apr 8;37(2):215-218. Epub 2019 Jan 8.

Centro de Investigación del Cáncer de Salamanca; Servicio de Hematología, Hospital Universitario de Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/hon.2570
Publisher Site
http://dx.doi.org/10.1002/hon.2570DOI Listing
April 2019

Current Status of Cardio-Oncology in Spain: A National Multidisciplinary Survey.

Rev Esp Cardiol (Engl Ed) 2019 Jan 6;72(1):84-86. Epub 2017 Dec 6.

Comisión de Trabajo Nacional de Cardio-Oncología Sociedad Española de Cardiología-Sociedad Española de Oncología Médica-Sociedad Española de Oncología Radioterápica-Sociedad Española de Hematología y Hemoterapia, Spain; Servicio de Cardiología, Hospital Universitario La Paz, Instituto de Investigación La Paz, CIBER-CV, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rec.2017.11.002DOI Listing
January 2019

A safety profile of medications used to treat Waldenström's macroglobulinemia.

Expert Opin Drug Saf 2018 06 6;17(6):609-621. Epub 2018 Jun 6.

a Servicio de Hematología, Hospital Universitario de Salamanca , Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cáncer de Salamanca, CIBERONC , Salamanca , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2018.1477936DOI Listing
June 2018

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.

N Engl J Med 2018 Jun 1;378(25):2399-2410. Epub 2018 Jun 1.

From the National and Kapodistrian University of Athens School of Medicine, Athens (M.A.D., E.K.); ASST Grande Ospedale Metropolitano Niguarda, Milan (A.T.), and Città della Salute Hospital and University, Turin (L.O.) - both in Italy; Concord Hospital, University of Sydney, Concord, NSW (J.T.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital, Melbourne, VIC (C.T.) - both in Australia; Hospital Universitario de Salamanca, Salamanca, Spain (R.G.-S.); Ottawa Hospital, University of Ottawa, Ottawa (D.M.), and Royal Victoria Hospital at McGill University Health Centre, Montreal (C.S.) - both in Canada; Département d'Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris (V.L.), Centre Hospitalier Universitaire de Nantes, Nantes (B.M.), and Centre Hospitalier Régional Universitaire de Lille, Institute of Hematolog-Tranfusion, Lille (C.H.) - all in France; Memorial Sloan Kettering Cancer Center, New York (M.L.P.); Colorado Blood Cancer Institute, Denver (J.V.M.); Dana-Farber Cancer Institute, Boston (S.P.T.); Pharmacyclics, Sunnyvale, CA (J.L., Z.S., T.G.); and Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany (C.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1802917DOI Listing
June 2018

Multiple Myeloma Minimal Residual Disease.

Cancer Treat Res 2016;169:103-122

Centro de Investigacion Medica Aplicada (CIMA), Clinica Universidad de Navarra, IDISNA, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40320-5_7DOI Listing
June 2017

Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case.

Clin Case Rep 2016 12 11;4(12):1096-1100. Epub 2016 Oct 11.

Department of Dermatology Complejo Asistencial Universitario de Salamanca/Instituto de investigación biomédica de Salamanca (CAUSA/IBSAL) Salamanca Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134131PMC
December 2016

[Primary amyloidosis].

Med Clin (Barc) 2016 08 13;147(3):121-6. Epub 2016 Apr 13.

Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.02.018DOI Listing
August 2016

WM, MYD88, and CXCR4: following the thread.

Blood 2016 08;128(6):746-8

UNIVERSITY HOSPITAL OF SALAMANCA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-06-723924DOI Listing
August 2016

Origin of Waldenstrom's macroglobulinaemia.

Best Pract Res Clin Haematol 2016 06 6;29(2):136-147. Epub 2016 Oct 6.

Servicio General de Citometría de la Universidad de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.08.024DOI Listing
June 2016

Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.

Clin Cancer Res 2016 Jan 4;22(1):207-17. Epub 2015 Sep 4.

Centro de Investigacion del Cancer-IBMCC (USAL-CSIC), Salamanca, Spain. Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. Servicio de Hematología, Hospital Universitario, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2796DOI Listing
January 2016

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Treatment for patients with newly diagnosed multiple myeloma in 2015.

Blood Rev 2015 Nov 12;29(6):387-403. Epub 2015 Jun 12.

Clínica Universidad de Navarra/Centro de Investigación Médica Aplicada (CIMA), Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2015.06.001DOI Listing
November 2015

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

Endocr Relat Cancer 2015 Aug 22;22(4):545-59. Epub 2015 Jun 22.

Genomic Oncology AreaGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, SpainHematology DepartmentVirgen de las Nieves University Hospital, Granada, SpainGenomic Epidemiology GroupGerman Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of BiologyUniversity of Pisa, Pisa, ItalyDepartment of HematologyHospital Universitario Doce de Octubre, Madrid, SpainArea of Genomic MedicineGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, SpainSemmelweis UniversityBudapest, HungaryHaematology DepartmentUniversity Hospital of Salamanca and IBSAL, Salamanca, SpainMedical University of LodzLodz, PolandINSERM UMR 1052/CNRS 5286Université Claude Bernard Lyon I, Lyon, FranceMorales Meseguer General University HospitalMurcia, SpainHaematoloy ClinikHolly Cross Cancer Center, Kielce, PolandINSERMU900, Genetic Epidemiology of Cancers team, Institut Curie, Mines ParisTech, Paris, FranceLife and Health Sciences Research Institute (ICVS)School of Health Sciences, University of Minho, Braga, PortugalICVS/3B's - PT Government Associate LaboratoryBraga/Guimarães, PortugalMolecular Oncology Research CenterBarretos Cancer Hospital, Barretos, BrazilIDIBELL - Catalan Institute of OncologyUniversity of Barcelona, Barcelona 08907, SpainDepartment of HematologyCracow University Hospital, Cracow, PolandOrgan CenterHospital of Southern Jutland, DK-6200 Aabenraa, DenmarkFaculty of Health SciencesInstitute of Regional Health Research, University of Southern Denmark, DK-5000 Odense C, DenmarkUO HematologyDepartment of Internal and Experimental Medicine, University of Pisa, Pisa, ItalyClinic of Biochemistry and ImmunologyLaboratory Center, Hospital of Southern Jutland, Aabenraa, DenmarkDepartment of HaematologyRigshospitalet and Roskilde Hospital, Copenhagen University, Copenhagen, Denmark Genomic Oncology AreaGENYO, Cen

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0029DOI Listing
August 2015

Is this the time to introduce minimal residual disease in multiple myeloma clinical practice?

Clin Cancer Res 2015 May 9;21(9):2001-8. Epub 2015 Mar 9.

Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2841DOI Listing
May 2015

Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.

Biochim Biophys Acta 2015 Mar 11;1849(3):353-66. Epub 2014 Dec 11.

Servicio de Hematología, Hospital Universitario, IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagrm.2014.12.002DOI Listing
March 2015

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma.

Ann Hematol 2014 Oct 27;93(10):1745-53. Epub 2014 May 27.

Department of Hematology, University Hospital of Salamanca, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2114-0DOI Listing
October 2014

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.

Cancer Epidemiol Biomarkers Prev 2014 Apr 12;23(4):670-4. Epub 2014 Feb 12.

Authors' Affiliations: Genomic Epidemiology Group, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Cracow University Hospital, Cracow; Medical University of Łodz; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Łodz; Rzeszow Regional Hospital, Rzeszow; Holycross Cancer Center, Kielce, Poland; Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; Morales Meseguer General University Hospital, Murcia; University Hospital of Salamanca, Salamanca; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government; Hematology Department, Virgen de las Nieves University Hospital, Granada; IDIBELL-Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; Semmelweis University, Budapest, Hungary; Institut National de la Santé et de la Recherche Medicale (INSERM) UMR 1052/CNRS 5286, Université Claude Bernard Lyon I, Lyon; Genetic Epidemiology of Cancer team, INSERM, U900, Institut Curie, Mines ParisTech, Paris, France; Department of Biology, University of Pisa, Pisa, Italy; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg; Organ Center, Hospital of Southern Jutland, Aabenraa; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense C; National Research Centre for the Working Environment, Copenhagen; Roskilde Hospital, Copenhagen University, Roskilde, Denmark; Life and Health Sciences Research Institute, University of Minho, Braga; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; UO Hematology, Department of Internal and Experimental Medicine, University of Pisa, Pisa, Italy; and Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1115DOI Listing
April 2014

Kikuchi-Fujimoto disease: a case supporting a role for human herpesvirus 7 involvement in the pathogenesis.

Rheumatol Int 2013 Dec 17;33(12):3065-8. Epub 2012 Nov 17.

Hematology Department, University Hospital of Salamanca, Paseo San Vicente 58-182, 37007, Salamanca, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-012-2562-6DOI Listing
December 2013

[Bisphosphonate-associated jaw osteonecrosis].

Med Clin (Barc) 2012 Dec 25;139(15):674-5. Epub 2012 Oct 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2012.07.019DOI Listing
December 2012

Genomic analysis of high-risk smoldering multiple myeloma.

Haematologica 2012 Sep 13;97(9):1439-43. Epub 2012 Feb 13.

Servicio de Hematología del Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBMCC (USAl-CIC), Universidad de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2011.060780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436247PMC
September 2012

Multiple myeloma: treatment evolution.

Hematology 2012 Apr;17 Suppl 1:S3-6

Servicio de Hematología, Hospital Universitatio de Salamanca, CIC, IBMCC (USAL-CSIC), Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/102453312X13336169154971DOI Listing
April 2012